BioWorld Asia

Oct. 10, 2007

Loss Of $1B Amgen Plant Is Major Blow To Ireland

The fallout from Amgen Inc.'s woes spread to Ireland last week, as the company said it would "postpone indefinitely" plans to build a $1 billion biologics production facility at Carrigtwohill, near Cork City. (BioWorld International) Read More

EU Industry Puts Brave Face On Clinical Trials Dead End

Vascular Growth Factor Linked To Motor Neurone Disease

Haptogen Acquisition Brings Shark Therapies To Wyeth

Drug Designer e-Therapeutics Using AIM To Boost Coffers

Other News To Note

Group Gains Big Pharma Aid For 'Safer' Stem Cell Program

Gilde Gets €150M For Second Health Care Fund

No Abstract Read More

French Biotech Growing But Still Lagging Behind

Today's news in brief

BioWorld

BioWorld briefs for July 7, 2026.

CINP 2026: Prenatal and adolescent stress shape brain vulnerability

BioWorld Science

Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

In the clinic for July 6, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.